Lista de obras -

5q21 deletion is often heterogeneous in prostate cancer

scientific article published on 24 January 2019

8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

artículo científico publicado en 2019

A non-diploid DNA status is linked to poor prognosis in renal cell cancer

scientific article published on 02 May 2020

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer

artículo científico publicado en 2019

Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma

scientific article published on 12 October 2018

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

artículo científico publicado en 2015

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

scientific article published in Scientific Reports

Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer

artículo científico publicado en 2020

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma

artículo científico publicado en 2020

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer

scientific article published on 22 December 2009

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

scientific article published on 19 November 2019

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

artículo científico publicado en 2014

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

artículo científico publicado en 2017

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

scientific article published on 02 November 2015

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

artículo científico publicado en 2016

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

artículo científico publicado en 2016

Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

scientific article published on 29 November 2019

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

artículo científico publicado en 2015

Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

artículo científico publicado en 2018

Expression of the immune checkpoint receptor TIGIT in seminoma

scientific article published on 31 May 2019

FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

artículo científico publicado en 2017

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

artículo científico publicado en 2017

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

artículo científico publicado en 2015

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

artículo científico publicado en 2015

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

artículo científico publicado en 2015

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

artículo científico publicado en 2018

High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer

scientific article published on 18 April 2020

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High homogeneity of MMR deficiency in ovarian cancer

artículo científico publicado en 2020

High homogeneity of mismatch repair deficiency in advanced prostate cancer

scientific article published on 06 December 2019

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer

artículo científico publicado en 2010

High mitochondria content is associated with prostate cancer disease progression

artículo científico publicado en 2013

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

artículo científico publicado en 2013

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

artículo científico publicado en 2017

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

artículo científico publicado en 2015

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

artículo científico publicado en 2017

Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas

scientific article published on 06 March 2020

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

artículo científico publicado en 2019

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

artículo científico publicado en 2018

Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer

artículo científico publicado en 2017

Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

artículo científico publicado en 2017

Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

artículo científico publicado en 2018

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

scientific article published on 01 May 2019

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

artículo científico publicado en 2015

Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

artículo científico publicado en 2020

MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes

artículo científico publicado en 2020

MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass

scientific article published on 14 February 2020

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

artículo científico publicado en 2018

NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

artículo científico publicado en 2014

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

artículo científico publicado en 2015

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

artículo científico publicado en 2017

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

artículo científico publicado en 2015

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

artículo científico publicado en 2019

Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes

artículo científico publicado en 2020

Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

artículo científico publicado en 2020

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

scientific article published on 23 December 2019

Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers

artículo científico publicado en 2017

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

artículo científico publicado en 2019

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

artículo científico publicado en 2015

SNW1 is a prognostic biomarker in prostate cancer

scientific article published on 01 May 2019

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

artículo científico publicado en 2013

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer

artículo científico publicado en 2016

The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

artículo científico publicado en 2019

The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression

artículo científico publicado en 2014

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

artículo científico publicado en 2017

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

artículo científico publicado en 2017

Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer

artículo científico publicado en 2019

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

artículo científico publicado en 2016

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

artículo científico publicado en 2020

VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

artículo científico publicado en 2015

p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.

artículo científico publicado en 2016

Lista de obras de

5q21 deletion is often heterogeneous in prostate cancer

8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

A non-diploid DNA status is linked to poor prognosis in renal cell cancer

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer

Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

Expression of the immune checkpoint receptor TIGIT in seminoma

FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High homogeneity of MMR deficiency in ovarian cancer

High homogeneity of mismatch repair deficiency in advanced prostate cancer

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer

High mitochondria content is associated with prostate cancer disease progression

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer

Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes

MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes

Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

SNW1 is a prognostic biomarker in prostate cancer

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer

The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.